"Experienced pharma executive, Dr Beata Niechoda, joins Noxopharm Board ....
The Noxopharm Board considered it was important to add to its breadth of expertise in light of its growing confidence in the Company becoming a major player in oncology. Dr Niechoda’s acceptance of the offer to join the Board reflects her confidence in the future of the Company.
In addition to Board duties, Dr Niechoda will work closely with the Company’s CEO, Dr Greg van Wyk, and the Company’s Global Medical Director, Dr Gisela Mautner, providing a high-level executive team with broad industry experience driving the Veyonda drug development program and commercial strategy.
(16th July 2019)
"Noxopharm (ASX:NOX) announces today that Dr Greg Van Wyk is departing the business." (24th of Sept)
"Dr Beata Edling steps down as Non-Executive Director" (today)
Hey QQQQQQQQQQ. Seriously?? Not one a word or even a question as to WTH is going on, no concerns or warnings.......nothing at all to say even though you have had plenty to say over at KZA. Your just never going to quite are you?
Ann: New Executive Appointments and Board Change, page-5
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72463 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 8810 | 1 |
View Market Depth
| Last trade - 10.16am 29/07/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable